Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non–Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201)
Jia‐Tao Zhang, Song Dong, Weiquan Gu, Ning Zhao, Yi Liang, Wen‐Fang Tang, Shuoyan Liu, Rui Wang, Guang-Suo Wang, Bin Peng, Nan Wu, Shi Yan, Guojun Geng, Zefeng Xie, Yan-Long Yang, Jianhua Zhang, Tao Zhang, Nuo Yang, Wenjie Jiao, Yuanyuan Xiong, Miao Cai, Fang Li, Rongrong Chen, Hong‐Hong Yan, Si‐Yang Maggie Liu, Xin Yi, Wen‐Zhao Zhong, Xue‐Ning Yang, Yi‐Long Wu
Topics & Concepts
MedicineInternal medicineOncologyClinical endpointAdjuvant therapyLung cancerStage (stratigraphy)Prospective cohort studyAdjuvantMinimal residual diseaseClinical trialCancerSurgeryPaleontologyLeukemiaBiologyLung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and Treatment